Severe hypomagnesaemia with tetany following ESHAP protocol
BACKGROUND: One patient with B-cell Non-Hodgkin's Lymphoma developed severe hypomagnesaemia and tetany 15 days after the first course of treatment with ESHAP protocol. This prompted a careful look at the incidence and severity of hypomagnesaemia during treatment with this combination chemotherapy. M...
Furkejuvvon:
| Publikašuvnnas: | BMC Blood Disord |
|---|---|
| Váldodahkki: | |
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
BMC
2002
|
| Fáttát: | |
| Liŋkkat: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC64621/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11801194/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1471-2326-2-1 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|